The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Long-term results of the children's cancer group studies for childhood acute lymphoblastic leukemia 1983–2002: A Children's Oncology Group Report
Open accessAbstract
The Children's Cancer Group enrolled 13 298 young people age <21 years on 1 of 16 protocols between 1983 and 2002. Outcomes were examined in three time periods, 1983–1988, 1989–1995, 1996–2002. Over the three intervals, 10-year event-free survival (EFS) for Rome/National Cancer Institute standard risk (SR) and higher risk (HR) B-precursor patients was 68 and 58%, 77 and 63%, and 78 and 67%, respectively, whereas for SR and HR T-cell patients, EFS was 65 and 56%, 78 and 68%, and 70 and 72%, respectively. Five-year EFS for infants was 36, 38, and 43%, respectively. Seminal randomized studies led to a number of important findings. Stronger post-induction intensification improved outcome for both SR and HR patients. With improved systemic therapy, additional intrathecal (IT) methotrexate effectively replaced cranial radiation. For SR patients receiving three-drug induction, iso-toxic substitution of dexamethasone for prednisone improved EFS. Pegylated asparaginase safely and effectively replaced native asparaginase. Thus, rational therapy modifications yielded better outcomes for both SR and HR patients. These trials provide the platforms for current Children's Oncology Group trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_25 · Cited by 45,181
Nonparametric Estimation from Incomplete Observations
Kaplan, E. L., & Meier, P. (1958) · Journal of the American Statistical Association · doi:10.1080/01621459.1958.10501452 · Cited by 39,158
Bennett, J. M., Catovsky, D., Daniel, M., Flandrin, G., Galton, D. A. G., Gralnick, H. R., & Sultan, C. (1976) · British Journal of Haematology · doi:10.1111/j.1365-2141.1976.tb03563.x · Cited by 5,602
A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk
Gray, R. J. (1988) · The Annals of Statistics · doi:10.1214/aos/1176350951 · Cited by 4,960
O'Brien, S. G., Guilhot, F., Larson, R. A., Gathmann, I., Baccarani, M., Cervantes, F., Cornelissen, J. J., Fischer, T., Hochhaus, A., Hughes, T., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022457 · Cited by 3,570
Deletion of IKZF1 and Prognosis in Acute Lymphoblastic Leukemia
Mullighan, C. G., Su, X., Zhang, J., Radtke, I., Phillips, L. A. A., Miller, C. B., Ma, J., Liu, W., Cheng, C., Schulman, B. A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808253 · Cited by 1,422
Self-citationSmith, M., Arthur, D., Camitta, B., Carroll, A. J., Crist, W., Gaynon, P., Gelber, R., Heerema, N., Korn, E. L., Link, M., et al. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.1.18 · Cited by 901
Self-citationBorowitz, M. J., Devidas, M., Hunger, S. P., Bowman, W. P., Carroll, A. J., Carroll, W. L., Linda, S., Martin, P. L., Pullen, D. J., Viswanatha, D., et al. (2008) · Blood · doi:10.1182/blood-2008-01-132837 · Cited by 842
Self-citationGenomic Analysis of the Clonal Origins of Relapsed Acute Lymphoblastic Leukemia
Mullighan, C. G., Phillips, L. A., Su, X., Ma, J., Miller, C. B., Shurtleff, S. A., & Downing, J. R. (2008) · Science · doi:10.1126/science.1164266 · Cited by 806
Schultz, K. R., Bowman, W. P., Aledo, A., Slayton, W. B., Sather, H., Devidas, M., Wang, C., Davies, S. M., Gaynon, P. S., Trigg, M., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.21.2514 · Cited by 701
Self-citationNguyen, K., Devidas, M., Cheng, S.-C., La, M., Raetz, E. A., Carroll, W. L., Winick, N. J., Hunger, S. P., Gaynon, P. S., Loh, M. L., et al. (2008) · Leukemia · doi:10.1038/leu.2008.251 · Cited by 582
Self-citationJAK mutations in high-risk childhood acute lymphoblastic leukemia
Mullighan, C. G., Zhang, J., Harvey, R. C., Collins-Underwood, J. R., Schulman, B. A., Phillips, L. A., Tasian, S. K., Loh, M. L., Su, X., Liu, W., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0811761106 · Cited by 562
Self-citationBhatia, S., Francisco, L., Carter, A., Sun, C.-L., Baker, K. S., Gurney, J. G., McGlave, P. B., Nademanee, A., O'Donnell, M., Ramsay, N. K. C., et al. (2007) · Blood · doi:10.1182/blood-2007-03-082933 · Cited by 540
Schrappe, M., Reiter, A., Zimmermann, M., Harbott, J., Ludwig, W.-D., Henze, G., Gadner, H., Odenwald, E., & Riehm, H. (2000) · Leukemia · doi:10.1038/sj.leu.2401973 · Cited by 531
Avramis, V. I., Sencer, S., Periclou, A. P., Sather, H., Bostrom, B. C., Cohen, L. J., Ettinger, A. G., Ettinger, L. J., Franklin, J., Gaynon, P. S., et al. (2002) · Blood · doi:10.1182/blood.v99.6.1986 · Cited by 492
Self-citationNachman, J. B., Sather, H. N., Sensel, M. G., Trigg, M. E., Cherlow, J. M., Lukens, J. N., Wolff, L., Uckun, F. M., & Gaynon, P. S. (1998) · New England Journal of Medicine · doi:10.1056/nejm199806043382304 · Cited by 445
Self-citationMitchell, C. D., Richards, S. M., Kinsey, S. E., Lilleyman, J., Vora, A., Eden, T. O. B., & the Medical Research Council Childhood Leukaemia Working Party (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05509.x · Cited by 418
Mattano, L. A., Sather, H. N., Trigg, M. E., & Nachman, J. B. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.18.3262 · Cited by 399
Self-citationFlohr, T., Schrauder, A., Cazzaniga, G., Panzer-Grümayer, R., van der Velden, V, Fischer, S., Stanulla, M., Basso, G., Niggli, F. K., Schäfer, B. W., et al. (2008) · Leukemia · doi:10.1038/leu.2008.5 · Cited by 361
Children's Cancer Group trials in childhood acute lymphoblastic leukemia: 1983–1995
Gaynon, P., Trigg, M., Heerema, N., Sensel, M., Sather, H., Hammond, G., & Bleyer, W. (2000) · Leukemia · doi:10.1038/sj.leu.2401939 · Cited by 319
Self-citationSeibel, N. L., Steinherz, P. G., Sather, H. N., Nachman, J. B., DeLaat, C., Ettinger, L. J., Freyer, D. R., Mattano, L. A., Hastings, C. A., Rubin, C. M., et al. (2008) · Blood · doi:10.1182/blood-2007-02-070342 · Cited by 312
Self-citationHilden, J. M. (2006) · Blood · doi:10.1182/blood-2005-07-3011 · Cited by 309
Ramanujachar, R., Richards, S., Hann, I., Goldstone, A., Mitchell, C., Vora, A., Rowe, J., & Webb, D. (2007) · Pediatric Blood & Cancer · doi:10.1002/pbc.20749 · Cited by 256
Akslen, L. A., & LiVolsi, V. A. (2000) · Cancer · doi:10.1002/(sici)1097-0142(20000415)88:8<1964::aid-cncr27>3.0.co;2-1 · Cited by 231
Tubergen, D. G., Gilchrist, G. S., O'Brien, R. T., Coccia, P. F., Sather, H. N., Waskerwitz, M. J., & Hammond, G. D. (1993) · Journal of Clinical Oncology · doi:10.1200/jco.1993.11.3.527 · Cited by 221
Self-citationAcute lymphoblastic leukaemia: a model for the pharmacogenomics of cancer therapy
Cheok, M. H., & Evans, W. E. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1800 · Cited by 217
Reaman, G. H., Sposto, R., Sensel, M. G., Lange, B. J., Feusner, J. H., Heerema, N. A., Leonard, M., Holmes, E. J., Sather, H. N., Pendergrass, T. W., et al. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.2.445 · Cited by 179
Self-citationWillemse, M. J. (2002) · Blood · doi:10.1182/blood.v99.12.4386 · Cited by 169
Lange, B. J., Bostrom, B., Cherlow, J. M., Sensel, M. G., La, M., Rackoff, W., Heerema, N. A., Wimmer, R. S., Trigg, M. E., & Sather, H. N. (2002) · Blood · doi:10.1182/blood.v99.3.825 · Cited by 139
Self-citationKadan‐Lottick, N. S., Dinu, I. A., Wasilewski‐Masker, K. J., Kaste, S. C., Meacham, L. R., Mahajan, A., Stovall, M. A., Yasui, Y., Robison, L. L., & Sklar, C. A. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.9088 · Cited by 139
Matloub, Y., Lindemulder, S., Gaynon, P. S., Sather, H. N., La, M., Broxson, E. H., Yanofsky, R., Hutchinson, R. J., Heerema, N. A., Nachman, J. B., et al. (2006) · Blood · doi:10.1182/blood-2005-12-011809 · Cited by 134
Self-citationNachman, J. B., Sather, H. N., Cherlow, J. M., Sensel, M. G., Gaynon, P. S., Lukens, J. N., Wolff, L. J., & Trigg, M. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.3.920 · Cited by 125
Self-citationNINE YEARS' EXPERIENCE WITH "TOTAL THERAPY" OF CHILDHOOD ACUTE LYMPHOCYTIC LEUKEMIA
Pinkel, D. P., Simone, J. V., Hustu, H. O., & Aur, R. J. A. (1972) · PEDIATRICS · doi:10.1542/peds.50.2.246 · Cited by 124
Liao, A. T., Chien, M. B., Shenoy, N. R., Mendel, D. B., McMahon, G., Cherrington, J. M., & London, C. A. (2002) · Blood · doi:10.1182/blood-2001-12-0350 · Cited by 124
Henze, G., Langermann, H., Brämswig, J. H., Breu, H., Gadner, H., Schellong, G., Weite, K., & Riehm, H. (1981) · Klinische Pädiatrie · doi:10.1055/s-2008-1034450 · Cited by 122
Bhojwani, D., Kang, H., de Menezes, R. X., Yang, W., Sather, H. N., Moskowitz, N. P., Min, D.-J., Potter, J. W., Harvey, R. C., Hunger, S. P., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.4519 · Cited by 118
Self-citationIgarashi, S., Manabe, A., Ohara, A., Kumagai, M., Saito, T., Okimoto, Y., Kamijo, T., Isoyama, K., Kajiwara, M., Sotomatsu, M., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.982 · Cited by 117
Conter, V., Valsecchi, M. G., Silvestri, D., Campbell, M., Dibar, E., Magyarosy, E., Gadner, H., Starý, J., Benoît, Y., Zimmermann, M., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60073-7 · Cited by 115
Freyer, D. R., Devidas, M., La, M., Carroll, W. L., Gaynon, P. S., Hunger, S. P., & Seibel, N. L. (2010) · Blood · doi:10.1182/blood-2010-07-294678 · Cited by 82
Self-citationSteinherz, P. G., Gaynon, P. S., Breneman, J. C., Cherlow, J. M., Grossman, N. J., Kersey, J. H., Johnstone, H. S., Sather, H. N., Trigg, M. E., Uckun, F. M., et al. (1998) · Cancer · Cited by 81
Self-citationBleyer, W. A., Sather, H. N., Nickerson, H. J., et al. (1991) · Journal of Clinical Oncology · doi:10.1200/jco.1991.9.6.1012 · Cited by 80
Self-citationHutchinson, R. J., Gaynon, P. S., Sather, H. N., Bertolone, S. J., Cooper, H., Tannous, R., Wells, L. M., Heerema, N. A., Sailer, S. L., & Trigg, M. E. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.03.009 · Cited by 57
Self-citationUnderstanding Medication Adherence in Pediatric Acute Lymphoblastic Leukemia: A Review
Pritchard, M. T., Butow, P. N., Stevens, M. M., & Duley, J. A. (2006) · Journal of Pediatric Hematology/Oncology · doi:10.1097/01.mph.0000243666.79303.45 · Cited by 53
Schrappe, M., Zimmermann, M., Möricke, A., Mann, G., Valsecchi, M. G., Bartram, C. R., Biondi, A., Panzer‐Grümayer, R., Schrauder, A., Locatelli, F., et al. (2008) · Blood · doi:10.1182/blood.v112.11.7.7 · Cited by 47
Schultz, K. R., Bowman, W. P., Slayton, W. B., Aledo, A., Devidas, M., Sather, H. N., Borowitz, M. J., Davies, S. M., Trigg, M. E., Pasut, B., et al. (2007) · Blood · doi:10.1182/blood.v110.11.4.4 · Cited by 40
Self-citationAbromowitch, M., Termuhlen, A. M., Chang, M. N., Perkins, S. L., Gross, T. G., Weinstein, H. J., & Finlay, J. L. (2008) · Blood · doi:10.1182/blood.v112.11.3610.3610 · Cited by 20
Bertrand, Y., Suciu, S., Benoît, Y., Robert, A., Nelken, B., Uyttebroeck, A., Lutz, P., Ferster, A., Baruchel, A., Norton, L., et al. (2008) · Blood · doi:10.1182/blood.v112.11.8.8 · Cited by 17
Management of Bcr–Abl-positive leukemias with dasatinib
Hochhaus, A. (2007) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.7.11.1529 · Cited by 16
Cited by
Hunger, S. P., Lu, X., Devidas, M., Camitta, B. M., Gaynon, P. S., Winick, N. J., Reaman, G. H., & Carroll, W. L. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.37.8018 · Cited by 1,180
Self-citationBiology, Risk Stratification, and Therapy of Pediatric Acute Leukemias: An Update
Pui, C.-H., Carroll, W. L., Meshinchi, S., & Arceci, R. J. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.30.7405 · Cited by 842
Self-citationPediatric acute lymphoblastic leukemia: where are we going and how do we get there?
Pui, C.-H., Mullighan, C. G., Evans, W. E., & Relling, M. V. (2012) · Blood · doi:10.1182/blood-2012-05-378943 · Cited by 500
Lipshultz, S. E., Scully, R. E., Lipsitz, S. R., Sallan, S. E., Silverman, L. B., Miller, T. L., Barry, E. V., Asselin, B. L., Athale, U., Clavell, L. A., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70204-7 · Cited by 446
Integrative Clinical Sequencing in the Management of Refractory or Relapsed Cancer in Youth
Mody, R. J., Wu, Y.-M., Lonigro, R. J., Cao, X., Roychowdhury, S., Vats, P., Frank, K. M., Prensner, J. R., Asangani, I., Palanisamy, N., et al. (2015) · JAMA · doi:10.1001/jama.2015.10080 · Cited by 411
Metadata
- Authors
- Gaynon, P. S., Angiolillo, A. L., Carroll, W. L., Nachman, J. B., Trigg, M. E., Sather, H. N., Hunger, S. P., Devidas, M., & for the Children's Oncology Group, A. C.
- Venue
- Leukemia
- Published
- 2009-12-17
- Volume
- 24
- Issue
- 2
- Pages
- 285-297
- ISSN
- 0887-6924 (ISSN-L)
- 1476-5551
- OpenAlex
- W1978709366
- Cited by
- 293
- References
- 49
- FWCI
- 20.69
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.